These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36588722)

  • 1. The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment.
    Zhou D; Duan Z; Li Z; Ge F; Wei R; Kong L
    Front Pharmacol; 2022; 13():1091779. PubMed ID: 36588722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Microenvironment: Lactic Acid Promotes Tumor Development.
    Gao Y; Zhou H; Liu G; Wu J; Yuan Y; Shang A
    J Immunol Res; 2022; 2022():3119375. PubMed ID: 35733921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive Environment in Tumors].
    Sakai C; Nishikawa H
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):222-226. PubMed ID: 29483409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of galectin‑3 in the tumor microenvironment and tumor metabolism (Review).
    Guo Y; Shen R; Yu L; Zheng X; Cui R; Song Y; Wang D
    Oncol Rep; 2020 Nov; 44(5):1799-1809. PubMed ID: 33000284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment.
    Fridman ES; Ginini L; Gil Z
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Reverse Warburg effect' of cancer‑associated fibroblasts (Review).
    Liang L; Li W; Li X; Jin X; Liao Q; Li Y; Zhou Y
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35425996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.
    Zhang Y; Zhang X; Meng Y; Xu X; Zuo D
    Int Immunopharmacol; 2022 Sep; 110():108994. PubMed ID: 35777265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis.
    Habanjar O; Diab-Assaf M; Caldefie-Chezet F; Delort L
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors.
    Gupta S; Dwarakanath BS
    Curr Med Chem; 2020; 27(24):4002-4015. PubMed ID: 29852858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy.
    Barar J; Omidi Y
    Bioimpacts; 2013; 3(4):149-62. PubMed ID: 24455478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal Alliance of Hypoxia-/HIF-1α-Driven Microenvironmental Traits Promoting Cancer Progression.
    Vaupel P; Multhoff G
    Adv Exp Med Biol; 2020; 1232():169-176. PubMed ID: 31893407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypoxia in the tumor microenvironment and targeted therapy.
    Chen G; Wu K; Li H; Xia D; He T
    Front Oncol; 2022; 12():961637. PubMed ID: 36212414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Tumor Microenvironment for Cancer Therapy.
    Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic alterations in the tumor microenvironment and their role in oncogenesis.
    Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R
    Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taming Tumor Glycolysis and Potential Implications for Immunotherapy.
    Ganapathy-Kanniappan S
    Front Oncol; 2017; 7():36. PubMed ID: 28348977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy.
    Lei J; Yang Y; Lu Z; Pan H; Fang J; Jing B; Chen Y; Yin L
    Biochem Pharmacol; 2022 Aug; 202():115153. PubMed ID: 35750199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration.
    Kolb D; Kolishetti N; Surnar B; Sarkar S; Guin S; Shah AS; Dhar S
    ACS Nano; 2020 Sep; 14(9):11055-11066. PubMed ID: 32706241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.